Jennifer Rickard1,2,3, Christian Ngarambe4, Leonard Ndayizeye4, Blair Smart5, Robert Riviello6,7, Jean Paul Majyambere8. 1. University Teaching Hospital of Kigali, Kigali, Rwanda. gehr0059@umn.edu. 2. Department of Surgery, University of Minnesota, 516 Delaware St SE, 11-134B, Minneapolis, MN, 55455, USA. gehr0059@umn.edu. 3. Human Resources for Health, Kigali, Rwanda. gehr0059@umn.edu. 4. Department of Surgery, University Teaching Hospital of Butare, Butare, Rwanda. 5. Department of Surgery, University of Southern California, Los Angeles, USA. 6. Human Resources for Health, Kigali, Rwanda. 7. Brigham and Women's Hospital, Center for Surgery and Public Health, Boston, USA. 8. University of Gitwe, Gitwe, Rwanda.
Abstract
BACKGROUND: Management of critically ill patients is challenging in a low-resource setting. In Rwanda, peritonitis is a common surgical condition where patients often present late, with advanced disease. We aim to describe critical care management of patients with peritonitis in Rwanda. METHODS: Data were collected at a tertiary referral hospital in Rwanda on patients undergoing operation for peritonitis over a 6-month period. Data included epidemiology, hospital course and outcomes. Patients requiring admission to the intensive care unit (ICU) were compared with those not requiring ICU admission using Chi-square and Wilcoxon rank-sum test. RESULTS: Over a 6-month period, 280 patients were operated for peritonitis. Of these, 46 (16.4%) were admitted to the ICU. The most common diagnoses were intestinal obstruction (N = 17, 37.0%) and typhoid intestinal perforation (N = 6, 13.0%). Thirty-nine (89%) patients had sepsis. The median American Society of Anesthesiologist score was 3 (range 2-4), and the median Surgical Apgar Score was 4 (range 0-6). Twenty-four (52.2%) patients required vasopressors, with dopamine and adrenaline being the only vasopressors available. Patients admitted to the ICU, compared with non-critically ill patients, were more likely to have major complications (80.4 vs. 14%, p < 0.001), unplanned reoperation (28 vs. 10%, p < 0.001) and death (72 vs. 8%, p < 0.001). CONCLUSION: Patients with peritonitis admitted to the ICU commonly presented with features of sepsis. Due to limited resources in this setting, interventions are primarily supportive with intravenous fluids, intravenous antibiotics, ventilator support and vasopressors. Morbidity and mortality remain high in this patient population.
BACKGROUND: Management of critically illpatients is challenging in a low-resource setting. In Rwanda, peritonitis is a common surgical condition where patients often present late, with advanced disease. We aim to describe critical care management of patients with peritonitis in Rwanda. METHODS: Data were collected at a tertiary referral hospital in Rwanda on patients undergoing operation for peritonitis over a 6-month period. Data included epidemiology, hospital course and outcomes. Patients requiring admission to the intensive care unit (ICU) were compared with those not requiring ICU admission using Chi-square and Wilcoxon rank-sum test. RESULTS: Over a 6-month period, 280 patients were operated for peritonitis. Of these, 46 (16.4%) were admitted to the ICU. The most common diagnoses were intestinal obstruction (N = 17, 37.0%) and typhoid intestinal perforation (N = 6, 13.0%). Thirty-nine (89%) patients had sepsis. The median American Society of Anesthesiologist score was 3 (range 2-4), and the median Surgical Apgar Score was 4 (range 0-6). Twenty-four (52.2%) patients required vasopressors, with dopamine and adrenaline being the only vasopressors available. Patients admitted to the ICU, compared with non-critically illpatients, were more likely to have major complications (80.4 vs. 14%, p < 0.001), unplanned reoperation (28 vs. 10%, p < 0.001) and death (72 vs. 8%, p < 0.001). CONCLUSION:Patients with peritonitis admitted to the ICU commonly presented with features of sepsis. Due to limited resources in this setting, interventions are primarily supportive with intravenous fluids, intravenous antibiotics, ventilator support and vasopressors. Morbidity and mortality remain high in this patient population.
Authors: Marcus J Schultz; Martin W Dunser; Arjen M Dondorp; Neill K J Adhikari; Shivakumar Iyer; Arthur Kwizera; Yoel Lubell; Alfred Papali; Luigi Pisani; Beth D Riviello; Derek C Angus; Luciano C Azevedo; Tim Baker; Janet V Diaz; Emir Festic; Rashan Haniffa; Randeep Jawa; Shevin T Jacob; Niranjan Kissoon; Rakesh Lodha; Ignacio Martin-Loeches; Ganbold Lundeg; David Misango; Mervyn Mer; Sanjib Mohanty; Srinivas Murthy; Ndidiamaka Musa; Jane Nakibuuka; Ary Serpa Neto; Mai Nguyen Thi Hoang; Binh Nguyen Thien; Rajyabardhan Pattnaik; Jason Phua; Jacobus Preller; Pedro Povoa; Suchitra Ranjit; Daniel Talmor; Jonarthan Thevanayagam; C Louise Thwaites Journal: Intensive Care Med Date: 2017-03-27 Impact factor: 17.440
Authors: Gentle S Shrestha; Arthur Kwizera; Ganbold Lundeg; John I Baelani; Luciano C P Azevedo; Rajyabardhan Pattnaik; Rashan Haniffa; Srdjan Gavrilovic; Nguyen Thi Hoang Mai; Niranjan Kissoon; Rakesh Lodha; David Misango; Ary Serpa Neto; Marcus J Schultz; Arjen M Dondorp; Jonarthan Thevanayagam; Martin W Dünser; A K M Shamsul Alam; Ahmed M Mukhtar; Madiha Hashmi; Suchitra Ranjit; Akaninyene Otu; Charles Gomersall; Jacinta Amito; Nicolas Nin Vaeza; Jane Nakibuuka; Pierre Mujyarugamba; Elisa Estenssoro; Gustavo A Ospina-Tascón; Sanjib Mohanty; Mervyn Mer Journal: Lancet Infect Dis Date: 2017-09 Impact factor: 25.071
Authors: Leonard Ndayizeye; Christian Ngarambe; Blair Smart; Robert Riviello; Jean Paul Majyambere; Jennifer Rickard Journal: Surgery Date: 2016-10-04 Impact factor: 3.982
Authors: R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno Journal: Intensive Care Med Date: 2013-01-30 Impact factor: 17.440
Authors: Juliana Barr; Gilles L Fraser; Kathleen Puntillo; E Wesley Ely; Céline Gélinas; Joseph F Dasta; Judy E Davidson; John W Devlin; John P Kress; Aaron M Joffe; Douglas B Coursin; Daniel L Herr; Avery Tung; Bryce R H Robinson; Dorrie K Fontaine; Michael A Ramsay; Richard R Riker; Curtis N Sessler; Brenda Pun; Yoanna Skrobik; Roman Jaeschke Journal: Am J Health Syst Pharm Date: 2013-01-01 Impact factor: 2.637
Authors: John G Meara; Andrew J M Leather; Lars Hagander; Blake C Alkire; Nivaldo Alonso; Emmanuel A Ameh; Stephen W Bickler; Lesong Conteh; Anna J Dare; Justine Davies; Eunice Dérivois Mérisier; Shenaaz El-Halabi; Paul E Farmer; Atul Gawande; Rowan Gillies; Sarah L M Greenberg; Caris E Grimes; Russell L Gruen; Edna Adan Ismail; Thaim Buya Kamara; Chris Lavy; Ganbold Lundeg; Nyengo C Mkandawire; Nakul P Raykar; Johanna N Riesel; Edgar Rodas; John Rose; Nobhojit Roy; Mark G Shrime; Richard Sullivan; Stéphane Verguet; David Watters; Thomas G Weiser; Iain H Wilson; Gavin Yamey; Winnie Yip Journal: Lancet Date: 2015-04-26 Impact factor: 79.321
Authors: Inipavudu Baelani; Stefan Jochberger; Thomas Laimer; Dave Otieno; Jane Kabutu; Iain Wilson; Tim Baker; Martin W Dünser Journal: Crit Care Date: 2011-01-10 Impact factor: 9.097
Authors: Hendry R Sawe; Juma A Mfinanga; Salum J Lidenge; Boniventura C T Mpondo; Silas Msangi; Edwin Lugazia; Victor Mwafongo; Michael S Runyon; Teri A Reynolds Journal: BMC Int Health Hum Rights Date: 2014-09-23